<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02592902</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-papilomatosis</org_study_id>
    <nct_id>NCT02592902</nct_id>
  </id_info>
  <brief_title>Recurrent Respiratory Papillomatosis and Extraesophageal Reflux</brief_title>
  <official_title>Recurrent Respiratory Papillomatosis and Extraesophageal Reflux</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to determine, whether patients with recurrent respiratory
      papillomatosis (RRP) suffer from extra oesophageal reflux more often than patients with
      laryngeal cyst (control group).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recurrent respiratory papillomatosis (RRP) is a chronic viral disease, which affects children
      and adults as well. It is characterised by grow of squamous cell tumours on mucosa of
      aerodigestive tract, with predilection for the larynx. The disease is caused by the human
      papillomavirus (HPV). However, in contrast to the low incidence of RRP, HPV prevalence is
      common. It is indicated that other factors may contribute to the pathogenesis of RRP. One
      such factor might be extraesophageal reflux (EER). We investigated whether patients with RRP
      suffer more often from EER.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of EER (percentage)</measure>
    <time_frame>36 months</time_frame>
    <description>The occurrence of extra oesophageal reflux will be assessed in both study groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of pepsin</measure>
    <time_frame>36 months</time_frame>
    <description>The presence of pepsin (yes-no) will be assessed in both study groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Recurrent Respiratory Papillomatosis</condition>
  <condition>Extra Oesophageal Reflux</condition>
  <condition>Laryngeal Cyst</condition>
  <arm_group>
    <arm_group_label>Recurrent respiratory papillomatosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with recurrent respiratory papillomatosis (RRP) - surgical collection of histology specimen from the vocal cords and rear laryngeal commissure, performance of immunohistochemical analysis - proof of pepsin, HPV 6 and 11, herpes simplex virus (HSV) type 2, chlamydia trachomasis, and assessment of the dysplasia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laryngeal cyst - control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with laryngeal cyst - surgical collection of a histology specimen from the vocal cords and rear laryngeal commissure, performance of immunohistochemical analysis - proof of pepsin and HPV 6 and 11, herpes simplex virus (HSV) type 2 and chlamydia trachomasis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical collection of histology specimen</intervention_name>
    <description>Collection of a histology specimen from the vocal cords and rear laryngeal commissure</description>
    <arm_group_label>Recurrent respiratory papillomatosis</arm_group_label>
    <arm_group_label>Laryngeal cyst - control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Performance of immunohistochemical analysis</intervention_name>
    <description>Immunohistochemical analysis - presence of pepsin, HPV 6 and 11, HSV 2 and chlamydia trachomasis</description>
    <arm_group_label>Recurrent respiratory papillomatosis</arm_group_label>
    <arm_group_label>Laryngeal cyst - control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 1-75 years

          -  cooperating patients with laryngeal papillomatosis

          -  patients tolerating impedance probe

          -  signed informed consent, consent with the examinations

          -  control group of patients with a cyst or vocal cord polyp (reflux finding score 0-2)
             and/or patients indicated to augmentation, medialization or lateralization of the
             vocal cords

        Exclusion Criteria:

          -  patients non-tolerating impedance catheter

          -  patients who do not understand Czech language

          -  patients who do not proclaim consent with enrolment into the study

          -  patients who do not proclaim consent with the planned examinations

          -  patients after surgical treatment of tumour of the swallowing or respiratory tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Formanek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vaclav Prochazka, MD,PhD,MSc</last_name>
    <phone>0042059737</phone>
    <phone_ext>2510</phone_ext>
    <email>vaclav.prochazka@fno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiri Hyncica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava-Poruba</city>
        <state>Czech Republic</state>
        <zip>708 52</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vaclav Prochazka, MD,PhD,MSc</last_name>
      <phone>0042059737</phone>
      <phone_ext>2510</phone_ext>
      <email>vaclav.prochazka@fno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Jiri Hyncica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Formanek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karol Zelenik, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pavel Kominek, prof,MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Radoslava Tomanova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <reference>
    <citation>Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008 Jul;118(7):1236-47. doi: 10.1097/MLG.0b013e31816a7135. Review.</citation>
    <PMID>18496162</PMID>
  </reference>
  <reference>
    <citation>Gallagher TQ, Derkay CS. Recurrent respiratory papillomatosis: update 2008. Curr Opin Otolaryngol Head Neck Surg. 2008 Dec;16(6):536-42. doi: 10.1097/MOO.0b013e328316930e.</citation>
    <PMID>19005325</PMID>
  </reference>
  <reference>
    <citation>Gallagher TQ, Derkay CS. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion. Expert Opin Pharmacother. 2009 Mar;10(4):645-55. doi: 10.1517/14656560902793530 . Review.</citation>
    <PMID>19284366</PMID>
  </reference>
  <reference>
    <citation>Goon P, Sonnex C, Jani P, Stanley M, Sudhoff H. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol. 2008 Feb;265(2):147-51. Epub 2007 Nov 29. Review.</citation>
    <PMID>18046565</PMID>
  </reference>
  <reference>
    <citation>Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, Van Zandt S, Whitt S, Shah K. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. 1992 Jan;102(1):9-13.</citation>
    <PMID>1309932</PMID>
  </reference>
  <reference>
    <citation>Maloney EM, Unger ER, Tucker RA, Swan D, Karem K, Todd NW, Reeves WC. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):711-5.</citation>
    <PMID>16847177</PMID>
  </reference>
  <reference>
    <citation>Mammas IN, Sourvinos G, Spandidos DA. Human papilloma virus (HPV) infection in children and adolescents. Eur J Pediatr. 2009 Mar;168(3):267-73. doi: 10.1007/s00431-008-0882-z. Epub 2008 Dec 3. Review.</citation>
    <PMID>19050916</PMID>
  </reference>
  <reference>
    <citation>McKenna M, Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol. 2005 May;69(5):597-605.</citation>
    <PMID>15850681</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recurrent respiratory papillomatosis</keyword>
  <keyword>extra oesophageal reflux</keyword>
  <keyword>laryngeal cyst</keyword>
  <keyword>phonosurgery</keyword>
  <keyword>oesophageal impedance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Papilloma</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

